Organisation paid for research Program year 2025 Source: CMS Open Payments

Bay State Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$836,255

106 payments

Through program year 2025, Bay State Clinical Trials is reported as receiving $836,255 in research payments, across 106 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$79,797	17
2024	Research	$275,763	28
2023	Research	$93,853	15
2022	Research	$22,629	6
2021	Research	$49,491	12
2020	Research	$195,969	21
2019	Research	$118,753	7

Breakdown

Who paid Research payments · program years 2019–2025

Allergan Inc. $364,213 40 payments
Ironwood Pharmaceuticals, Inc $290,191 30 payments
AbbVie, Inc. $181,851 36 payments

Studies the money was for Research payments · program years 2019–2025

C3300-201 $290,191 30 payments
A Study Evaluating the Efficacy and Safety of BOTOX Intravesical Instillation in Patients with Overactive Bladder and Urinary Incontinence $191,443 21 payments
Androderm 24-Hr ABPM $123,279 7 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) $83,280 13 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis Bladder Pain Syndrome (IC BPS) $55,736 11 payments
Androderm 24-Hr ABPM $49,491 12 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitisx2FBladder Pain Syndrome (ICx2FBPS) $20,354 5 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis;Bladder Pain Syndrome $15,343 4 payments
M21-459 - Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis Bladder Pain Syndrome (IC BPS) $5,890 2 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis Bladder Pain Syndrome (IC BPS) $1,248 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.